| Thomas P Quinn, LCSW | |
|
230 North Rd, Poughkeepsie, NY 12601-1328 | |
| (845) 486-2703 | |
| (845) 471-3406 |
| Full Name | Thomas P Quinn |
|---|---|
| Gender | Male |
| Speciality | Social Worker - Clinical |
| Location | 230 North Rd, Poughkeepsie, New York |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1003983628 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 1041C0700X | Social Worker - Clinical | R042300-1 (New York) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Thomas P Quinn, LCSW 230 North Rd, Poughkeepsie, NY 12601-1328 Ph: (845) 486-2703 | Thomas P Quinn, LCSW 230 North Rd, Poughkeepsie, NY 12601-1328 Ph: (845) 486-2703 |
News Archive
Researchers at Wake Forest University Baptist Medical Center, and others, report in the current online edition of the American Journal of Nephrology. The researchers suggest screening other relatives for undetected kidney disease.
Georgia State University's H. Elliott Albers, the Regents' Professor of Neuroscience and director of the Center for Behavioral Neuroscience, has received a four-year, $1.3 million grant from the National Institutes of Health to study how the body's internal clock is "reset," a key to understanding more about sleep and other disorders affecting human health.
The FRS Company, a developer and distributor of FRS® Healthy Energy® products, announced today that it has received $23.1 million in its latest financing round led by Oak Investment Partners, LLC. Oak Investment Partners was an early investor in The FRS Company, and its continued support of FRS validates the company's aggressive business strategy for national and international expansion and explosive sales growth.
Merck & Co., Inc. announced today that the U.S. Food and Drug Administration's (FDA) Vaccines and Related Biological Products Advisory Committee agreed that efficacy, immunogenicity and safety data from clinical trials in males support the use of GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] in boys and men 9 through 26 years of age for the prevention of genital warts caused by human papillomavirus (HPV) types 6 and 11.
› Verified 7 days ago
Adrienne Strother, Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 23 W Arnold Rd, Poughkeepsie, NY 12601 Phone: 845-505-8439 | |
Ms. Ellen M Smith, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 31 Collegeview Ave, Poughkeepsie, NY 12603 Phone: 845-485-2004 Fax: 845-622-3851 | |
Ms. Karen Payne Whitton, LCSW Clinical Social Worker Medicare: Accepting Medicare Assignments Practice Location: 230 North Rd, Poughkeepsie, NY 12601 Phone: 845-485-9700 | |
Sharon Doane, LCSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 29 N Hamilton St, Poughkeepsie, NY 12601 Phone: 845-452-1110 | |
Irene Humbach, LCSW PC Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 11 Woodward Rd, Poughkeepsie, NY 12603 Phone: 845-485-5933 Fax: 845-485-5933 | |
Rachel Denise Fisher-johnson, MSW Clinical Social Worker Medicare: Not Enrolled in Medicare Practice Location: 230 North Rd, Poughkeepsie, NY 12601 Phone: 845-838-4900 Fax: 845-838-4915 |